PharmClass

MAFSirolimus Tablet 0.5 mg, 1 mg, 2 mg

For kidney transplant immunosuppression in patients with:
1) Evidence of CNI-induced nephrotoxicity on allograft biopsy OR
2) Elevated serum creatinine levels precluding the achievement of optimal therapeutic blood levels of CNI OR
3) History of CNI drug hypersensitivity

MAFSirolimus Oral Solution 1 mg/mL

For kidney transplant immunosuppression in patients with:
1) Evidence of CNI-induced nephrotoxicity on allograft biopsy OR
2) Elevated serum creatinine levels precluding the achievement of optimal therapeutic blood levels of CNI OR
3) History of CNI drug hypersensitivity